FSA Wealth Management’s AbbVie ABBV Stock Holding History

FSA Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$275K	Buy	1,188 +37	+3%	+$7.54K	0.1%	44
2025 Q2	$214K	Sell	1,151 -57	-5%	-$10.6K	0.08%	52
2025 Q1	$253K	Sell	1,208 -38	-3%	-$7.39K	0.11%	47
2024 Q4	$221K	Buy	1,246 +4	+0.3%	+$735	0.09%	49
2024 Q3	$245K	Buy	+1,242	New	+$232K	0.1%	47
2024 Q1	$243K	Buy	1,333 +173	+15%	+$29.8K	0.11%	45
2023 Q4	$180K	Buy	+1,160	New	+$169K	0.09%	53
2021 Q1	–	Sell	-1,516	Closed	-$162K	–	47
2020 Q4	$162K	Buy	+1,516	New	+$146K	0.08%	61
2020 Q3	–	Sell	-1,716	Closed	-$168K	–	56
2020 Q2	$168K	Buy	1,716 +32	+2%	+$2.82K	0.11%	59
2020 Q1	$128K	Buy	1,684 +60	+4%	+$5.11K	0.11%	67
2019 Q4	$144K	Buy	+1,624	New	+$135K	0.1%	72

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FSA Wealth Management's ABBV Position: Q3 2025 in Review

FSA Wealth Management increased its AbbVie (ABBV) stake by 3.2% in Q3 2025, buying an estimated $7.54K and bringing the position to 1,188 shares worth $275K. The position accounts for 0.1% of the portfolio, ranked #44.

FSA Wealth Management first reported a position in ABBV in Q4 2019 and has held it in 11 quarters since. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

FSA Wealth Management held 1,188 shares of AbbVie worth $275K as of Q3 2025.
FSA Wealth Management bought 37 AbbVie shares in Q3 2025, an estimated $7.54K.
AbbVie made up 0.1% of FSA Wealth Management's portfolio in Q3 2025, its #44 holding.
FSA Wealth Management first reported a position in AbbVie in Q4 2019 and has held it in 11 quarters since.
3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on FSA Wealth Management's 13F filing for Q3 2025, filed 17 Nov 2025.